Company Analysis

Alpha Cognition Inc. (ACOG)

Nasdaq: ACOG · Biological Products, (No Diagnostic Substances) · Grapevine, TX · filing with the SEC since 2015
Grade4.2
◀ Past 3.8● Present 3.3▶ Future 5.2
5 est.

Who runs Alpha Cognition Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Mcfadden Michael E.
Chief Executive Officer. First filing Nov 2024, latest Jan 13, 2026, 1 filing in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
10 people on the record since 2024
Officerssales are open-market, Oct 26, 2025 to Oct 26, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
D'Angelo LaurenChief Operating OfficerNov 2024May 19, 2026none
Mcfadden Michael E.Chief Executive OfficerNov 2024Jan 13, 2026none
Du Henry HuyVP Finance and AccountingNov 2024Jan 13, 2026none
Directorssales are open-market, Oct 26, 2025 to Oct 26, 2026
NameRoleFirst filingLatest filingSales, 12 months
Wills Robert JamesdirectorApr 2025Aug 24, 2026none
Sensenig BethanydirectorApr 2026Apr 17, 2026none
Bakshi Rajeev KumardirectorNov 2024Jan 16, 2026none
Cawkell Kenneth AnthonydirectorNov 2024Jan 16, 2026none
Mertz Leonard PowelldirectorNov 2024Jan 16, 2026none
Mertz Phillip JosephdirectorNov 2024Jan 16, 2026none
Owners of more than 10% of a classsales are open-market, Oct 26, 2025 to Oct 26, 2026
NameRoleFirst filingLatest filingSales, 12 months
Opaleye Management Inc.10% ownerFeb 2026Oct 26, 2026none
Earlier names on the record1, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ACOG · research, not advice